Galera, P., Russell, B., Epstein, I. B., Berg, S. A., Mantia, C., Shavakhi, M., Abdelnaser, A., McGregor, B. A., Ravi, A., Thapa, B., Bellmunt, J. (2025). Treatment decision patterns post–enfortumab vedotin plus pembrolizumab in metastatic urothelial cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16562